Publications

The economic importance of the pharmaceutical industry manifests in many ways: over the past 25 years, its companies have created thousands of additional jobs, and now almost one Swiss franc in ten is generated along the value chains of their research, development and production activities. The real economic output of the pharmaceutical industry tripled in the last ten years and was responsible for over 40 percent of Swiss economic growth. The basis for this outstanding achievement is the enormous capacity for innovation and productivity, coupled with international competitiveness.

The things that help the patients of today are crucial to the future of Switzerland as a pharmaceutical location. The Annual Report 2025 shows how medical advances, security of supply and economic strength are connected – and the direction that politics now needs to take.

The Innovation Report 2025 presents the latest drug approvals in Switzerland, key research trends and the tangible benefits of innovative therapies for patients and the healthcare system.